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Abstract 8 
In this work, the antioxidant gallic acid (GA) has been encapsulated in microspheres prepared with poly-9 
ε-caprolactone (PCL) and incorporated into polyamide (PA) obtaining the cosmeto-textile. The topical 10 
application of the cosmeto-textile provides a reservoir effect in the skin delivery of GA. The close contact 11 
of the cosmeto-textile, containing microsphere-encapsulated GA (ME-GA), with the skin and their 12 
corresponding occlusion may be the main reasons that explain the crossing of active principle (GA) 13 
through the skin barrier, located in the stratum corneum, and its penetration into the different 14 
compartments of the skin, epidermis and dermis.  15 
An ex vivo assessment was performed to evaluate the antioxidant effect of the ME-GA on the stratum 16 
corneum (SC) using the thiobarbituric acid reactive species (TBARS) test. The test is based on a non-17 
invasive ex vivo methodology that evaluates lipid peroxides formed in the outermost layers of the SC 18 
from human volunteers after UV radiation to determine the effectiveness of an antioxidant. In this case, a 19 
ME-GA cosmeto-textile or ME-GA formulation were applied to the skin in vivo and lipid peroxidation 20 
(LPO) in the horny layer were determined after UV irradiation. This methodology may be used as a 21 
quality control tool to determine ex vivo the percentage of LPO inhibition on human SC for a variety of 22 
antioxidants that are topically applied, in this case GA. 23 
Results show that LPO formation was inhibited in human SC when GA was applied directly or embedded 24 
in the cosmeto-textile, demonstrating the effectiveness of both applications. The percentage of LPO 25 
inhibition obtained after both topical applications was approximately 10% for the cosmeto-textile and 26 
41% for the direct application of microspheres containing GA. This methodology could be used to 27 
determine the effectiveness of topically applied antioxidants encapsulated in cosmeto-textiles on human 28 
SC. 29 
Keywords: gallic acid; microspheres; cosmeto-textiles; skin absorption; lipoperoxidation 30 
 31 
1. INTRODUCTION 32 
Biofunctional textiles are materials that exert a biological effect on human skin. Such textiles constitute 33 
the basis for the delivery system of cosmetic or pharmaceutical substances when the textiles come into 34 
contact with the skin[1]. Active substances are commonly incorporated into the vehicles, which may 35 
break when a garment rubs the skin, allowing for the release of the compounds directly to be absorbed 36 
by the skin. These cosmeto-textiles, with a slow released of the active compound into the skin, may help 37 
people with sensitive skin. 38 
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 In fact, there are several textile products currently in the market that claim to have properties usually 39 
found in cosmetics[2], such as moisturizing, slimming, energizing, refreshing, relaxing or vitalizing 40 
properties, as well as UV protection[3-4] or simply fragrance. Thus, there is a real need to develop test 41 
methods to verify the effectiveness and durability of these claimed properties[5].  42 
The specific case of UV protection, sunscreen lotions, clothing and shade structures provide protection 43 
from the deleterious effects of ultraviolet radiations (UV). The formation of reactive oxygen species 44 
(ROS) with UV exposure and their effect on lipids has also been extensively studied[6]. ROS have been 45 
implicated lipid oxidation [7], which can alter tissue structure via cross-linking, fragmentation, etc. ROS 46 
was part of the damage processes in SC. Some studies[8] demonstrated a marked decrease in 47 
intercellular delamination energy with increasing UV exposure indicating UV radiation causes a 48 
significant decrease in cellular cohesion and thus an alteration of intercellular lipid or corneodesmosome 49 
structure. 50 
In case of cloths when UV hits the textile, different types of interactions occur depending upon the 51 
substrate and its conditions. The UV protection by textile materials is a function of the chemical 52 
characteristics, physico-chemical type of fibre, presence of UV absorbers, construction of fabric, 53 
thickness, porosity, extension of the fabric, moisture content of the fabrics, colour and the finishing given 54 
to the fabric.  The UV transmitted through textile fabrics consists of the unchanged waves that pass 55 
through the interstices of the fabric as well as scattered waves that have interacted with the fabrics. 56 
Another part is absorbed when it penetrates the sample, and is converted into a different energy form. 57 
The portion of radiation that travels through the fabric and reaches the skin is referred to as the 58 
transmission component[9]. This portion of radiation could be one of the reasons to study the antioxidant 59 
protection effect of a biofunctional textile prepared with an antioxidant active. 60 
Gallic acid (GA) is a polyhydroxyphenolic compound present in leafy vegetables, fruits, and nuts[10-12]. 61 
GA exhibits variety of biological activities including antioxidant[13-14], anti-tumor[11, 15-17], anti-62 
inflammatory[18] and anti-bacterial[19-20]. Several line of evidence has shown that GA inhibits tumor cell 63 
growth, migration and invasion in vitro[21]. GA has recently been applied in cosmeto-textiles as an active 64 
component[22].  65 
In this work, the GA was selected and incorporated into polyamide (PA) through microspheres prepared 66 
from poly-ε-caprolactone (PCL). PCL is an aliphatic polyester having good chemical resistance to 67 
solvents[23]. It is biodegradable and non-toxic to the human body[24]. And, it has the advantage of 68 
controlling the release of the active principle over a period of several days to several weeks in contrast to 69 
natural hydrophobic polymers, which have a shorter period of release[25]. Therefore PCL microspheres 70 
have been used as a vehicle for textile application to study the absorption and desorption properties 71 
thereof when incorporated into PA[22].  72 
Polyamide (PA) was used as a textile fabric in this work to obtain biofunctional textiles because of their 73 
comfort when in contact with the skin. PA has been used for a number of industrial, apparel, and medical 74 
applications, such as wound sutures, artiﬁcial tendons, and medical packaging, due to its excellent wear 75 
resistance, strength, toughness, elastic recovery, low initial modulus, appearance retention, ease of 76 
coloration, and high resistance to rupture[26]. 77 
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 Using the in vitro methodology of percutaneous absorption, it is possible to detect the amount of the 78 
active principle that penetrates each skin layer from a given cosmeto-textile[27]. It is reasonable to 79 
assume that the reservoir capacity of a cosmeto-textile, close contact with the skin and the 80 
corresponding skin occlusion may be the main factors that determine how an active principle (e.g., GA) 81 
crosses the skin barrier, located in the stratum corneum, and penetrates the different compartments of 82 
the skin. The in vitro skin delivey of PA containing ME-GA has previously been explored  the results 83 
obtained suggested that GA penetrates through the skin detecting at different skin layers (stratum 84 
corneum, epidermis and dermis)[22]. 85 
The aim of this work was to assess the antioxidant efficacy of a cosmeto-textile containing microsphere-86 
encapsulated GA. Our study involves a topical antioxidant strategy to prevent damage to skin specially 87 
the lipid fraction. The antioxidant capacity was determined using human volunteers after topical cosmeto-88 
textile application. An ex vivo assessment was performed to evaluate the protection effect on the stratum 89 
corneum (SC) after cosmeto-textile application. The lipid peroxide formation was determined using the 90 
thiobarbituric acid reactive species test (TBARS). This test is a non-invasive ex vivo method that uses 91 
tape strips of the outermost layers of the SC from human volunteers to evaluate the effectiveness of an 92 
antioxidant[28]. 93 
2. MATERIALS AND METHODS 94 
2.1 Materials 95 
The textile bandages used were knitted fabrics (plain stitch) of polyamide 78/68/1 (DeFiber, S.A., Spain). 96 
Poly(vinyl alcohol) (PVA) (87–89% hydrolyzed, MW 31 000–50 000 Da) was used as a dispersant for 97 
microsphere preparation; poly-ε-caprolactone (PCL) (MW 45 000 Da) was used as the microsphere 98 
polymer. Both PVA and PCL were supplied by Sigma-Aldrich (Madrid, Spain). Gallic acid (GA), as the 99 
active ingredient, was supplied by Sigma-Aldrich (Madrid, Spain). All chemicals used were of analytical 100 
grade. Methanol (HPLC grade) and phosphoric acid were supplied by Merck (Darmstadt, Germany). 101 
2.2 PCL-Microspheres  102 
The solvent evaporation method was used to obtain microspheres by forming microemulsions (w1/o/w2 103 
double emulsion)[22]. The preparation procedure was carried out twice to obtain a sufficient volume of 104 
microspheres for all textile bandage applications. 105 
Briefly, 20 ml of a 2.91% (w/w) dispersion of GA in water was added to 20 ml of 2.91% (w/w) PCL in 106 
dichloromethane. A simple emulsion (w1/o) was generated by mechanical agitation (ULTRA-TURRAX 107 
T25, IKA) for 25 min at 24 000 rpm. This simple emulsion was then added to a continuous phase 108 
consisting of 200 ml of an aqueous PVA solution (1.96% (w/w)) and was emulsified for 30 more minutes 109 
at 20 000 rpm, resulting in a double emulsion (w1/o/w2). The method used was carried out at 4 ºC [29]. 110 
The mixture was maintained under agitation at 400 rpm (20 h) at room temperature, leading to solvent 111 
evaporation and consequently microsphere formation. The percentage of GA in the formulation is 0.49 % 112 
(w/v) and its percentage related to microspheres without water was 11.60 %(w/w).  113 
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 PCL microspheres of gallic acid (ME-GA) (mixture of both preparations) were applied to textiles (322 ± 1 114 
cm² area) by bath exhaustion, with a bath ratio of 1/5 (1 g textile per 5 ml of treatment bath), at 50°C for 115 
60 min with manual stirring performed every 10 min. To quantify the amount of product absorbed onto 116 
the fabrics, the dry samples were weighed before and after 24 h of application under standard ambient 117 
conditions (23±2°C and 55±5% relative humidity).  118 
The GA present in the formulations and absorbed onto the fabrics was extracted with methanol during 15 119 
minutes under ultrasounds and quantified using a Hitachi-Merck HPLC equipped with an L-6000 120 
Intelligent Pump, AS-4000 Autosampler and L-4250 UV-Vis Detector. The column used was a LiChrocart 121 
250-4/Lichrosorb RP-18 (5 mm) (Darmstadt, Germany). The mobile phase was 90% water (with 0.7% 122 
H3PO4)/10% methanol flowed at a rate of 1 ml/min. GA detection was conducted at 280 nm with a 123 
retention time of 6.9 min. The area below the peak in the chromatogram was used to calculate the 124 
concentration of GA using external standards that displayed linearity over a concentration range of 0.25 125 
to 100 mg/ml. The equation yielding the regression line through the experimental values was (ABS= 126 
15967·[GA]+4417.1, r²= 0.9999). This analytical methodology was fully validated. 127 
 128 
2.3 Size of PCL microspheres 129 
 130 
The size distribution and polydispersity of the PCL microspheres were measured by dynamic light 131 
scattering (DLS) (Zetasizer Nano ZS ZEN3600; Malvern Instruments Ltd., Malvern, Worcestershire, UK). 132 
The non-invasive backscattering technology was used to minimize multiple scattering effects without the 133 
need for sample dilution. The size distribution and polydispersity measurements were performed at room 134 
temperature with polystyrol/polystyrene cells (Ref 67.754 Sarstedt). The scattered light was detected at 135 
an angle of 173º. Each sample was measured in triplicate. The data were interpreted by considering the 136 
size distribution by intensity. All data were collected and analyzed using the program DTS (dispersion 137 
technology software) provided by Malvern Instruments Ltd. 138 
2.4 Volunteers 139 
The experimental protocol was conducted with 8 healthy Caucasian volunteers (all women) with 140 
phototypes II, III and IV [30]. The mean age of the volunteers was 36.8 ± 13.6 years (range years) (Table 141 
1). The volunteers refrained from using cosmetics, body oils, sunscreens or moisturizers on their arms 4 142 
days prior to the study and during the study except for the 2 formulations selected. The participants were 143 
given a detailed description of the study, and the corresponding written consent forms were obtained. 144 
The study design was approved by the local ethics committee (IQAC-CSIC, Barcelona, Spain). 145 
Table1. Age and phototype of volunteers. 146 
Volunteer 1 2 3 4 5 6 7 8 Mean ± SD 
Age  24 24 28 60 34 36 33 55 36.8 ± 13.6 
Phototype II III IV II IV IV IV III  
 147 
2.5 In vivo cosmeto-textile and formulation application  148 
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 The cosmeto-textiles (polyamide containing ME-GA) and control textiles (polyamide without antioxidant) 149 
were applied on subjects’ arms, maintaining close contact with the skin over a period of 4 days as a 150 
bandage application.  151 
Moreover, the formulation containing PCL microspheres of GA (ME-GA) was directly applied to the skin 152 
of each volunteer. A skin area of 18 x 5 cm² was marked on the volunteers’ forearms. Formulations were 153 
applied by each volunteer twice a day over a period of 4 days on one forearm with a final total amount of 154 
6 mL of ME-GA applied (327 µg/cm² of GA).  The other forearm was used as a control without 155 
antioxidant application.  156 
2.6 Tape stripping and lipid extraction 157 
The tape stripping of the SC of each forearm and arm was carried out on the 4th day in a conditioned 158 
room at 25 ±1ºC and  50 ± 2% relative humidity using D-Squame tape (φ= 22 mm, CuDerm, Dallas, 159 
USA) previously pressed onto the skin with a roller and stripped in one quick move.  160 
The weight of each tape was determined directly (Mettler Toledo Excellence XA105, Greifensee, 161 
Switzerland) before and after stripping, and the weight of the SC removed was then determined. Then, 162 
half of the strips were fixed in a glass plate and irradiated using a light source simulating UV solar 163 
radiation (3.045 J/min cm², Suntest CPS, Atlas, USA). This radiation is double the maximum radiation 164 
input in one day in June in Catalonia (1.50-1.84 J/min cm² equivalent to 21-26.5 MJ/m² per day [31]). The 165 
UV exposure time was 60 min, yielding a UV irradiation intensity of 182.7 J/cm².  166 
The SC lipids from a group of 3 strips were extracted with methanol (Merck, Darmstadt, Germany) with 167 
sonicated in a Labsonic 1510 device (B. Braun, Melsungen, Germany) for 15 min.  168 
 169 
2.7 Determination of lipoperoxidation (LPO)  170 
Lipid peroxides (LPO species) were measured by the thiobarbituric acid (TBA) assay [28]. The 171 
thiobarbituric acid-reactive species (TBARS) were quantified by spectrophotometry at 534 nm (Cary 300 172 
Bio UV-Visible Spectrophotometer, Varian, USA). At low pH and elevated temperature, MDA readily 173 
participates in a nucleophilic addition reaction with TBA, generating a red, fluorescent 1:2 MDA:TBA 174 
adduct. 175 
The results obtained were expressed as malonaldehyde bis(dimethyl acetal) equivalents (µM MDA) 176 
using a standard curve for pure MDA-TBA complexes.  The calibration curve was obtained by using 177 
MDA (Sigma, St Louis, MO, USA) in different concentrations (0-40 µM). Additionally, negative and 178 
positive controls were quantified using 0 and 100 µM MDA. The calibration curve was prepared on each 179 
day of the experimental study. The general regression equation obtained from the experimental analysis 180 
was ABS= -0.0006 [MDA]²+0.0751[MDA]-0.0137 (correlation coefficient, r²= 0.999). The repeatability and 181 
reproducibility of the analytical method was confirmed by the absorbance of the MDA positive control 182 
(100 µM MDA). The mean value obtained for this MDA control (100 µM) was 2.3314± 0.0206. The 183 
results for each experimental analysis indicated good repeatability and intra-day precision with an 184 
acceptable R.S.D. (<0.50%). 185 
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 Briefly, a 0.5 ml volume of SC lipid extracts and standard MDA solutions was added to aliquots (1 ml) of 186 
a solution made up with 0.4% TBA (Sigma, St Louis, MO, USA) and 15% trichloroacetic acid (TCA) 187 
(Merck, Darmstadt, Germany) in 100 ml of HCl solution (0.25 M). The mixture was incubated for 1 h in a 188 
boiling water bath. Fresh TBA /TCA stock solution was prepared on each day of analysis.  189 
Following the experimental procedure[28], the amount of LPO formed from unprotected skin (placebo) 190 
and the amount of LPO formed from protected skin (antioxidant application) were calculated based on 191 
the absorbance values obtained for the SC extraction samples by MDA determination. Therefore, the 192 
percentage of LPO inhibition (% LPO inhib.) was determined from the difference in the amount of LPO 193 
formed between the SC placebos and SC antioxidant samples.  194 
2.8 Statistics 195 
Global results were calculated as medians with their 0.25 and 0.75 percentiles (0.25; 0.75). The Mann-196 
Whitney test was applied for group comparisons. The software used was STATGRAPHICS plus 5. 197 
Significant differences in the mean values were evaluated by an F-test. A p value below 0.05 was 198 
considered significant. 199 
3. RESULTS AND DISCUSSION  200 
 201 
Formulations containing PCL microspheres were prepared using a double emulsion method, as 202 
described in the Materials and Methods section.  The diameter of the particles in the ME-GA mixture was 203 
measured with Dynamic Light Scattering (DLS) and results indicated the presence of  microspheres with 204 
a homogeneous size distribution of 2692 nm with a polydispersity index of 0.437. Moreover, the amount 205 
of GA present in the PCL microsphere formulation was determined by HPLC using an external 206 
calibration curve. The amount of GA in the ME-GA formulation was 0.49 ± 0.01% (w/v). 207 
 208 
The performance of biofunctional textiles with release properties could be affected by a number of 209 
factors, such as biocompatibility, biostability, biodegradability, drug delivery efficiency, drug quantity, 210 
system design and control in terms of dose, rate and time of development[32]. Thus, it is very important 211 
to establish the precise amount of active agents present in a textile before its use as a textile drug 212 
delivery system. In this study, PCL microspheres were applied by bath exhaustion, as discussed in the 213 
‘Materials and Methods’ section. Textiles were submitted to a bath impregnation formulation that 214 
contained ME-GA. Table 2 shows the weights of the PA bandages before and after application. The final 215 
percentages of dry product incorporated into the fabrics were calculated based on the weight difference 216 
between the initial dry fabrics and the dry fabrics after the bath exhaustion process. The median amount 217 
of dry product applied was 11.59±0.65% over weight of fiber (owf). Taking into account the percentage of 218 
GA in PCL microspheres without water (11.60% (w/w)), the mean of the treated area of fabric (322 cm²) 219 
and the mass increase of the fabric (0.9124 g), the mean amount of GA/cm² in the textile calculated 220 
accounts for 350 ± 17 µg GA/cm². 221 
 222 
 223 
 224 
 225 
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 Table 2. Weights of PA bandage before and after ME-GA application by bath exhaustion and the total 226 
dry product on the textile after water evaporation 227 
Volunteer 
PA WEIGHT after 24h at 23ºC and  55%Hr Dry Product 
Bandage before ME-
GA application 
(g) 
Bandage after ME-
GA application 
(g) 
Mass 
Increased  
(g) 
% owf of ME-
GA 
1 8.3385 9.2989 0.9604 11.52 
2 5.6969 6.3860 0.6891 12.09 
3 8.3429 9.3572 1.0143 12.06 
4 8.4450 9.4432 0.9982 11.82 
5 8.2804 9.2498 0.9694 11.71 
6 8.1517 8.9948 0.8431 10.34 
Mean 7.8759 8.7883 0.9124 11.59 
 228 
 229 
 230 
In addition, a piece of treated textile was used to extract GA with methanol using an ultrasound bath to 231 
quantify GA by HPLC. The amount of GA incorporated into the textiles was determined to be 376.63 ± 232 
19.93 µg GA/cm² fabric. The theoretical value of approximately 350 µg GA/cm² on PA obtained from 233 
mass increase of fabric confirms the equivalence of the two methodologies in determining the amount of 234 
GA in the textiles. In addition, this result indicated that it was substantively between the textile and active 235 
agent, which could play an important role during the application process.  236 
 237 
After analytical determination, microspheres of GA were applied in vivo. Cosmeto-textiles containing ME-238 
GA were fixed on one arm of 6 volunteers, and the ME-GA formulation (concentration of 0.49% w/v) was 239 
directly applied on one forearm of 6 volunteers; both applications were maintained for 4 days. The GA 240 
applied in skin was of 377 µg/cm² for cosmeto-textile and 327 µg/cm² for formulation. The outermost 241 
layers of SC were then obtained using tape as described in the Materials and Methods. The results 242 
obtained for the mean weight of SC for both applications were similar. The mean weights of the SC 243 
obtained were 0.83 ±0.11 and 0.76 ± 0.17 mg/3 tape strips for the cosmeto-textile and direct application 244 
modes, respectively. 245 
Half of the SC layers in the strips (from unprotected and protected skin) obtained by each application 246 
mode were irradiated with an intensity of 182.7 J/cm². LPO compounds were then extracted from a group 247 
of 3 strips. The LPO values and the percentage of LPO inhibition due to the application of the cosmeto-248 
textiles and the formulation were determined for all volunteers.  249 
The LPO results obtained in µM from unprotected and protected skin are shown in Table 3, as well as 250 
the percentages of LPO inhibition (%). Figure 1 presents the medians of the results obtained from 251 
unprotected and protected skin when ME-GA was applied via a cosmeto-textile or directly. 252 
 253 
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 Table 3. LPO values obtained from unprotected and protected skin with ME-GA for each volunteer when 254 
cosmeto-textiles and formulation were applied. 255 
  LPO (µM)   
Application Volunteer Unprotected skin 
Protected 
skin 
% LPO 
inhib. 
% LPO median  
(percentil 0.25; 
0.75) 
ME-GA Cosmeto-
Textiles 
1 0.7899 0.7245 8.28 
10.12  
(8.68; 15.73) 
2 0.5891 0.4860 17.51 
3 0.9059 0.8120 10.37 
4 0.1820 0.1640 9.87 
5 0.2967 0.1904 35.81 
6 0.5205 0.4939 5.11 
ME-GA formulation 
3 0.8223 0.3310 59.75 
41.45  
(34.43; 52.97) 
4 0.0470 0.0304 35.19 
5 0.2517 0.1140 54.72 
6 0.3155 0.2077 34.17 
7 0.3803 0.1989 47.71 
8 0.0963 0.0956 0.77 
 256 
As shown, the amounts of LPO obtained from unprotected skin were higher than those obtained from 257 
protected skin using ME-GA via each application mode (Figure 1). These results demonstrate a lower 258 
extent of formation of lipid peroxides in the SC of skin protected after UV irradiation when the antioxidant 259 
was used. The amounts of LPO obtained for each volunteer were highly variable due to the effects of 260 
several variables such as the amount of GA delivered into skin, the different skin types of the volunteers, 261 
and the amount of SC present in the samples. Therefore, even the results are not statistically significant 262 
for any of the applications there is an appreciable difference in the amounts of LPO obtained from 263 
unprotected and protected skin.  264 
 265 
Despite the variation in the percentage of LPO inhibition, the results indicate a clear inhibition of LPO for 266 
both ME-GA applications. It appears that the ME-GA used has a protective effect on human SC against 267 
lipid peroxidation, with the percentage of LPO inhibition reaching 10.12% LPO (8.68; 15.73) for the 268 
cosmeto-textile application and 41.45% LPO (34.43; 52.97) for the direct application of the ME-GA 269 
formulation.  270 
Similar amounts of SC were retrieved on the 3 strips: 0.79 ± 0.15 mg/3 tape strips. The percentage of 271 
LPO inhibition was calculated based on the total amount of lipid peroxides on SC treated or not treated 272 
with antioxidant. The results of LPO inhibition (%/mg of SC) obtained were 11.28%/mg (8.09; 35.58) for 273 
the ME-GA cosmeto-textiles and 43.65%/mg (14.37; 53.38) for the ME-GA formulation. 274 
TBARS assay is a convenient and simple method which has been frequently used as a standard 275 
biomarker of LPO in vivo with human plasma and urine. LPO is the major reaction taking place under 276 
oxidative stress and assumed to play an important role in the pathogenesis and progression of many 277 
diseases[33]. This paper reports a non-invasive ex vivo method to detect LPO in human skin using tape 278 
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 strips of the outmost layers of SC from human volunteers. This strategy permits evaluate the 279 
effectiveness of topical treatment with antioxidant against oxidative stress caused by UV exposure. 280 
In a previous study[22], a specific in vitro percutaneous absorption methodology was designed to 281 
demonstrate the delivery of an encapsulated component from a textile to the different skin layers 282 
(stratum corneum, epidermis or dermis). The percutaneous absorption results obtained are shown in 283 
Figure 2. 284 
 285 
The percutaneous absorption results indicate that the skin penetration of GA released from PCL 286 
microspheres that were applied directly to the skin was higher than that observed when GA was 287 
embedded within the cosmeto-textiles. In all cases, the highest amount of GA that penetrated the skin 288 
was observed in the superficial layer (SC, stratum corneum), where the amount was 5 to 10 times higher 289 
than that in the epidermis or the dermis. In conclusion, an interesting reservoir effect may have been 290 
promoted when biofunctional textiles were used.  291 
Results concerning skin delivery to the different skin layers (stratum corneum, epidermis and dermis) 292 
showed that ME-GA incorporated into the cosmeto-textiles displayed high GA retention. This retention 293 
capacity of cosmeto-textiles was deduced by the lower amount of antioxidant found in the inner skin 294 
layers compared to that measured after the direct application of ME-GA. This suggests a slower but 295 
continuous release of antioxidant to the skin when ME-GA cosmeto-textile is applied. The high amount of 296 
GA in the SC layer for both applications can be related to the extensive LPO inhibition observed after UV 297 
irradiation of the tape strips containing SC. In addition, a stronger protective effect of the ME-GA 298 
formulation was observed compared to the ME-GA cosmeto-textiles. It may also be due to the different 299 
amounts of GA found in the SC for the two different types of applications. The cosmeto-texile presents 300 
two diffusion phases, first this active compound must diffuse from the fabric to the skin surface when the 301 
cosmeto-textile is topically applied. The second phase is the penetration of the compound at the different 302 
skin layers. The low release of GA from the cosmeto-textiles may suggest a slow but continuous release 303 
of the antioxidant to the skin. 304 
Although the content of antioxidant present in the skin was lower for the cosmeto-textile mode of 305 
application than for the direct mode of application, it is important to note that the amount released 306 
demonstrated sufficient capacity to combat lipid peroxidation in human SC. The use of cosmeto-textiles 307 
allowed for a reservoir effect with a prolonged and controlled dose of the antioxidant such that the 308 
corresponding UV protection was also prolonged. 309 
4. CONCLUSIONS 310 
This study explored the antioxidant efficacy of a cosmeto-textile containing ME-GA and a formulation 311 
containing gallic acid in microspheres. The effectiveness of the antioxidant via the ME-GA cosmeto-312 
textile and direct application routes was determined by a non-invasive ex vivo method with tape strips of 313 
the outermost layers of the SC of human volunteers. The antioxidant was applied to prevent lipid 314 
peroxidation in the horny layer after UV irradiation.  315 
The results indicate that LPO was inhibited in human SC when GA was applied, demonstrating the 316 
effectiveness of both applications. The capacity of each application route to reduce LPO in the outermost 317 
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 layers of the skin was confirmed. The percentage of LPO inhibition obtained after each topical 318 
application was approximately 10% for the cosmeto-textile route and 41% for the direct route.  319 
This finding is in accord with the results obtained from a percutaneous absorption study in which PCL 320 
microspheres containing GA and the textiles were impregnated with the same formulation. Percutaneous 321 
absorption data indicate a high level of skin penetration for GA that was directly applied within PCL 322 
microspheres. The high extent of LPO inhibition measured is proportional to the amount of GA measured 323 
in the outermost layers of the skin. 324 
The LPO methodology could be used to verify the antioxidant capacity of encapsulated substances 325 
transferred into human skin by cosmeto-textiles that can deliver specific doses of active ingredients. The 326 
incorporation of antioxidants into cosmeto-textiles allows for the natural photoprotection capacity of the 327 
skin to be enhanced when such textiles are used for prolonged application periods.  328 
 329 
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Figure 1. LPO values obtained from unprotected and protected skin with ME-GA cosmeto-
textiles and ME-GA formulation (p>0.05). 
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Figure 2. In vitro percutaneous absorption of GA from PCL-microspheres and from biofunctional 
textiles (PA). (SC: stratum corneum; E: epidermis; D: dermis; R. Fluid: receptor fluid) 
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